Difference between revisions of "Bjerkvig R, et al. Nat. Rev. Cancer (2005) cited as Ref 12 in DOI: 10.1038/s41392-020-0110-5 (Q9275)"

@@ Property / PubMed ID @@
+16327766
@@ Property / PubMed ID: 16327766 / rank @@
+Normal rank
@@ Property / Publication Date @@
+Timestamp +2005-01-01T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 year
Before 0
After 0
-Timestamp
++2005-01-01T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+year
 Before
 After
@@ Property / Publication Date: 2005 / rank @@
+Normal rank
@@ Property / Published In Name String @@
+Nat. Rev. Cancer
@@ Property / Published In Name String: Nat. Rev. Cancer / rank @@
+Normal rank
@@ Property / Volume @@
@@ Property / Volume: 5 / rank @@
+Normal rank
@@ Property / title @@
+Opinion: the origin of the cancer stem cell: current controversies and new insights (English)
+Normal rank
@@ Property / Page(s) @@
+-904
@@ Property / Page(s): 899-904 / rank @@
+Normal rank
@@ Property / Fourth Author string @@
+Najbauer J
@@ Property / Fourth Author string: Najbauer J / rank @@
+Normal rank
@@ Property / Fifth Author string @@
+Terzis AJ
@@ Property / Fifth Author string: Terzis AJ / rank @@
+Normal rank

Latest revision as of 13:51, 22 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

Language	Label	Description	Also known as
English	Bjerkvig R, et al. Nat. Rev. Cancer (2005) cited as Ref 12 in DOI: 10.1038/s41392-020-0110-5	Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8